Toggle navigation
Home
Search
Services
Blog
Contact
About
St. Louis Metropolitan Target Cities Program
Keehn, Barbara
Missouri State Department of Mental Health, Jefferson City, MO, United States
Search grants from Barbara Keehn
Search grants from Missouri State Department of Mental Health
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
RNA markers of renal damage due to obstruction
IGF-1 and the initiation of non-melanoma skin cancer
Connexin mutations in deafness
SBIR Phase I: From Annotations to Adaptations
RUI:Insertion of Protease-Binding Loops into Interleukin-18
Recently added grants:
The Role of Ceramides in Skeletal Muscle
Cellular and Biochemical Pathways of Adipose Metabolism and Thermogenesis
Role of Afadin in 3D epithelial plexus morphogenesis and beta cell mass
Extracellular matrix proteoglycans regulate toll-like receptors 4 and 9
New Functions and Specificities of the Arg/N-Degron Pathway
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Center for Substance Abuse Treatment (CSAT)
Type
Unknown (U95)
Project #
5U95TI000662-03
Application #
2291055
Study Section
Project Start
1993-09-30
Project End
1998-09-29
Budget Start
1995-09-30
Budget End
1996-09-29
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Institution
Name
Missouri State Department of Mental Health
Department
Type
DUNS #
878143742
City
Jefferson City
State
MO
Country
United States
Zip Code
65102
Related projects
NIH 1995
U95 TI
St. Louis Metropolitan Target Cities Program
Keehn, Barbara / Missouri State Department of Mental Health
NIH 1994
U95 TI
St. Louis Metropolitan Target Cities Program
Keehn, Barbara / Missouri State Department of Mental Health
Publications
Guydish, Joseph; Claus, Ronald E
(2002)
Improving publicly-funded drug abuse treatment systems: the Target Cities Initiative.
J Psychoactive Drugs 34:1-6
Comments
Be the first to comment on Barbara Keehn's grant